Shelby Chase Howell, MD | |
40023 Cross Creek Dr., Hamilton, MS 39746-8801 | |
(662) 343-5093 | |
(662) 343-9105 |
Full Name | Shelby Chase Howell |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 40023 Cross Creek Dr., Hamilton, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225069677 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 09619 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shelby Chase Howell, MD 123 Main St N, Amory, MS 38821-3416 Ph: (662) 256-7112 | Shelby Chase Howell, MD 40023 Cross Creek Dr., Hamilton, MS 39746-8801 Ph: (662) 343-5093 |
News Archive
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return, according to a recent study conducted by radiologists at the University of California-San Francisco.
Carrying extra weight earlier in life increases the risk of developing problems with mobility in old age, even if the weight is eventually lost, according to new research out of the Sticht Center on Aging at Wake Forest University School of Medicine.
Syntaxin, a biotechnology company developing novel biopharmaceuticals to control cell secretion, today announces its partner Allergan, Inc has initiated two Phase II trials to evaluate the safety and efficacy of its re-targeted endopeptidase drug candidate AGN-214868. The Phase II trials will be focused on patients with post herpetic neuralgia (PHN) and overactive bladder.
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that its upcoming conference call on its third quarter financial results will also provide some representative examples of data being collected from patients in its clinical trials for forms of macular degeneration.
A collaborative group of researchers from The University of Texas Medical Branch at Galveston and the Faculty of Medicine of Sao Jose do Rio in Brazil is the first to report that wild monkeys in the Americas are transmitting the Zika virus to humans via mosquitoes, making complete eradication of the virus in the Americas very unlikely.
› Verified 6 days ago